Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 601 publications
Alogliptin Mitigates Methotrexate-Induced Nephrotoxicity in a Rat Model: Antagonizing Oxidative Stress, Inflammation and Apoptosis.
Journal: International journal of molecular sciences
Published: August 07, 2025
Ultrasensitive detection of alogliptin via fluorescence quenching of terbium-doped carbon quantum dots: mechanistic investigation, Box-Behnken optimization and analytical evaluation.
Journal: RSC advances
Published: April 19, 2025
Evaluation and comparison of efficacy and safety of mitochondrial modulator (Imeglimin) and DPP-4 inhibitors in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis.
Journal: Journal of endocrinological investigation
Published: March 28, 2025
Effects of antidiabetic drugs on the level of serum uric acid in patients who have type 2 diabetes.
Journal: Saudi medical journal
Published: March 17, 2025
Collaboration to transition members to preferred formulary dipeptidyl-peptidase-4 inhibitor.
Journal: The American journal of managed care
Published: January 23, 2025
Development of Alogliptin Oral-Dissolving Films with Optimized Therapeutic Outcomes.
Journal: Pharmaceutical research
Published: January 10, 2025
Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer's disease.
Journal: NPJ systems biology and applications
Published: January 09, 2025
Pharmacokinetics and Safety of a Fixed-Dose Combination of Alogliptin and Extended-Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults.
Journal: Clinical pharmacology in drug development
Published: January 02, 2025
Cross-disease modeling of peripheral blood identifies biomarkers of type 2 diabetes predictive of Alzheimer's disease.
Journal: bioRxiv : the preprint server for biology
Published: December 23, 2024
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Fractures in Type 2 Diabetes Mellitus Patients: A Bayesian Network Meta-Analysis.
Journal: Current reviews in clinical and experimental pharmacology
Published: December 19, 2024
Last Updated: 10/31/2025